Israel China Biotechnology (ICB) Ltd (ICB) — Long-term Investment Intensity
Israel China Biotechnology (ICB) Ltd (ICB) has a Long-term Investment Intensity of 44.9% as of June 2019. Long-term investments of ILA6.17 Million represent 44.9% of total assets of ILA13.74 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Israel China Biotechnology (ICB) Ltd book value and equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Israel China Biotechnology (ICB) Ltd Long-term Investment Intensity (2018–2018)
This chart shows how Israel China Biotechnology (ICB) Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of June 2019, the intensity stands at 44.9%, reflecting long-term investments of ILA6.17 Million against total assets of ILA13.74 Million ILA. Also explore Israel China Biotechnology (ICB) Ltd (ICB) total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Israel China Biotechnology (ICB) Ltd (2018–2018)
The table below presents the year-by-year Long-term Investment Intensity for Israel China Biotechnology (ICB) Ltd from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Israel China Biotechnology (ICB) Ltd.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 34.3% | ILA3.39 Million | ILA9.88 Million | — |